About Us
The 2nd International Clinical Trials Conference 2024 organized by King Abdullah International Medical Research Center (KAIMRC) and the Saudi Clinical Trials Enterprise (SCTE), stands as a dynamic platform for global collaboration in clinical trials. Our objectives encompass fostering international exchange, sharing experiences, and building networks among researchers, sponsors, and solution providers. We will delve into futuristic advancements, including biomedical R&D, medical innovation, patient experiences, decentralized trials, and data quality. Additionally, discussions will address the pivotal role of clinical trials in setting up a vibrant medical innovation and state of the art healthcare as part of the Saudi Vision 2030, aligning global practices with the country’s commitment to advancing healthcare and R&D aspirations. The conference, under the leadership of KAIMRC and its partners from SCTE, is poised to address challenges and to encourage dialogue on overcoming obstacles and driving positive changes in the clinical trials field.
Objectives
- Discussing how to strengthen clinical trials enterprise utilizing Artificial Intelligence (AI) to optimize clinical trial design and conduct.
- Contributing to positioning KSA in the clinical trials global map by enhancing global partnership opportunities
- Bridging the gap between site, sponsors, and other clinical trial stakeholders
- Sharing and adopting strategies for developing successful clinical trials agreements and budgeting.
- Discussing the future of decentralized clinical trials (DCTs) using advanced technology
- Sharing international experiences and best practices in building clinical trial enterprises and setting the stage for high quality data
TARGET AUDIENCE
- Clinicians and principal investigators
- Scientists
- Clinical Research Coordinators
- Pharmacists
- Nurses
- Data Managers
- Research Administrators and Executives
- IRB members
- Quality Assurance
- Pharmaceutical and Biotech Companies
- Clinical Research Organizations